Back to Archived Journals » Core Evidence » Volume 14

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Total article views   HTML views PDF downloads Totals
16,904 Dovepress* 9,698+ 1,551 11,249
PubMed Central* 7,206 750 7,956
Totals 16,904 2,301 19,205
*Since 26 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar